TYMS and cancer: A recent, large, prospective trial (Schwab et al, 2008) on cancer patients treated with 5FU monotherapy confirmed a significant––although weak––link between mutant MTHFR C677T genotypes and FU toxicity but, at odds with our results, also found a significant correlation with the 2R/2R TYMS genotype.